United States

People: Merck & Co Inc (MRK)

MRK on New York Consolidated

28 Apr 2017
Change (% chg)

$-0.25 (-0.40%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Davis, Robert 

Mr. Robert M. Davis is Chief Financial Officer, Executive Vice President of Merck & Co., Inc., since April 23, 2014. Mr. Davis is responsible for the Company’s global financial organization, investor relations, corporate strategy and business development, global facilities, and the Company’s joint venture relationships. Prior to starting his employment with the Company, Mr. Davis served as Corporate Vice President and President, Medical Products of Baxter International, Inc. (“Baxter”), a healthcare company, a position he had held since October 2010. In that position, Mr. Davis was responsible for all aspects of commercial, R&D, quality, regulatory, manufacturing and supply chain functions. Prior to that position, Mr. Davis served as Corporate Vice President and President, Renal Division of Baxter in 2010 and had previously served as Baxter’s Corporate Vice President and Chief Financial Officer from 2006 to 2010.

Basic Compensation

Total Annual Compensation, USD 3,605,760
Restricted Stock Awards, USD 2,103,990
Long-Term Incentive Plans, USD --
All Other, USD 1,609,250
Fiscal Year Total, USD 7,319,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --